Y. Acin

In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells.

O. Bernard, S. Létard, P. Dubreuil, 2012, Blood.

Online supplementary information for the article ‘ Masitinib in advanced gastrointestinal stromal tumor after failure of imatinib : a randomized controlled open-label trial ’

J. Blay, F. Bertucci, A. Cesne, 2014 .

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer

B. Melichar, G. Deplanque, P. Flynn, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer.

B. Melichar, G. Deplanque, P. Flynn, 2015 .

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial.

J. Blay, F. Bertucci, B. V. Van Tine, 2014 .

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer

G. Deplanque, D. Piquemal, A. Moussy, 2015, Annals of Oncology.

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

A. Cesne, I. Ray-Coquard, N. Isambert, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Online supplementary information for the article ‘ Masitinib in advanced gastrointestinal stromal tumor after failure of imatinib : a randomized controlled open-label trial ’

F. Bertucci, A. Cesne, I. Ray-Coquard, 2014 .